BIOX Stock Intrinsic Value – BIOCERES CROP SOLUTIONS Reports Fourth Quarter Earnings Results for FY2023

September 15, 2023

☀️Earnings Overview

On September 11 2023, BIOCERES CROP SOLUTIONS ($NASDAQ:BIOX) reported their earnings results for the fourth quarter of FY2023, which ended on June 30 2023. Total revenue for the quarter was USD 104.7 million, a decrease of 1.0% compared to the same period last year. Net income for the quarter was USD -3.8 million, a decrease from the -5.2 million reported for the same quarter in FY2022.

Stock Price

The market responded positively to the announcement, as the stock opened at 11.3 and closed at 11.7, representing a 3.9% increase from the prior closing price of 11.3. The company offered a positive outlook for the upcoming year, citing the “strengthening global demand for their products and services”. They also highlighted the “significant investments made in research and development” during the fourth quarter.

These investments helped drive the company’s growth in revenue and EPS, despite facing some challenges in the agricultural sector due to weather and other factors. With the strengthening global demand for their products and services, combined with their commitment to research and development, they are well-positioned to achieve further success in the upcoming year. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for BIOX. More…

    Total Revenues Net Income Net Margin
    419.8 16.7 4.0%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for BIOX. More…

    Operations Investing Financing
    5.66 2.9 14.82
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for BIOX. More…

    Total Assets Total Liabilities Book Value Per Share
    824.1 494 4.72
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for BIOX are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    34.5% 13.0% 12.6%
    FCF Margin ROE ROA
    -2.9% 11.1% 4.0%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis – BIOX Stock Intrinsic Value

    At GoodWhale, we analyzed the fundamentals of BIOCERES CROP SOLUTIONS to determine its fair value. Our proprietary Valuation Line calculations revealed that the fair value of the share is around $13.0. Currently, BIOCERES CROP SOLUTIONS stock is traded at $11.7, a fair price which is undervalued by 10.1%. This provides investors an opportunity to purchase the stock at a lower price than the estimated intrinsic value. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis

  • Peers

    In the world of agriculture, there are many companies vying for supremacy. Two of the most prominent companies in this arena are Bioceres Crop Solutions Corp and its competitor, Argo Living Soils Corp. Both of these companies have developed innovative products and services that have revolutionized the way farmers grow crops. While Bioceres has a slight edge in terms of market share, Argo is not far behind and is constantly innovating in order to catch up. The competition between these two companies is fierce, and it is benefiting farmers all over the world.

    – Argo Living Soils Corp ($OTCPK:ARLSF)

    Argo Living Soils Corp is a Canadian company that specializes in the production of organic soils and amendments. The company’s products are used by commercial growers, farmers, and home gardeners. Argo Living Soils Corp has a market cap of 1.61M as of 2022. The company’s return on equity is 83.33%.

    – EarthRenew Inc ($OTCPK:VVIVF)

    The company’s market cap is 13.41M as of 2022. The company’s ROE is -24.3%. The company focuses on providing renewable energy solutions to businesses and homeowners. The company operates in three segments: Solar, Wind, and Other. The Solar segment provides solar power systems for residential and commercial customers. The Wind segment provides wind turbines for residential and commercial customers. The Other segment provides energy storage solutions and energy efficiency products.

    – Kiwa Bio-Tech Products Group Corp ($OTCPK:KWBT)

    Kiwa Bio-Tech Products Group Corp is a China-based company that engages in the research, development, manufacture, and sale of bio-pesticides and bio-fertilizers. The company has a market cap of 56.48k as of 2022 and a Return on Equity of -5.54%. Kiwa Bio-Tech Products Group Corp is a leading player in the bio-pesticides and bio-fertilizers industry in China. The company’s products are sold to over 30 provinces and municipalities in China, and are exported to over 50 countries and regions worldwide.


    Investors in BIOCERES CROP SOLUTIONS were pleased with the company’s fourth quarter earnings results for FY2023, which were reported on September 11 2023. The stock price reflected the good news and increased on the same day. Investors should keep an eye on the company as it could be a good option in the long term with careful monitoring.

    Recent Posts

    Leave a Comment